Patents & the progress of personalized medicine: biomarkers research as lens.

Annals of health law Pub Date : 2009-01-01
Matthew Herder
{"title":"Patents & the progress of personalized medicine: biomarkers research as lens.","authors":"Matthew Herder","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This article addresses the barriers to personalized medicine, focusing on the burgeoning field of biomarkers research. The author begins by framing intellectual property issues as more than a product of industry incentives and suggests that these issues are deeply entangled with other barriers facing personalized medicine such as regulatory framework deficiencies. The author proposes a set of future research questions to more fully define the barriers to biomarkers research and to uncover which corrective measures may be effective. The author concludes by recommending an integration of regulatory and patent reforms, with a call to action by scholars, scientists, representatives of the biopharmaceutical industry, and policy-makers.</p>","PeriodicalId":79788,"journal":{"name":"Annals of health law","volume":"18 2","pages":"187-229, 8 p. preceding i"},"PeriodicalIF":0.0000,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of health law","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This article addresses the barriers to personalized medicine, focusing on the burgeoning field of biomarkers research. The author begins by framing intellectual property issues as more than a product of industry incentives and suggests that these issues are deeply entangled with other barriers facing personalized medicine such as regulatory framework deficiencies. The author proposes a set of future research questions to more fully define the barriers to biomarkers research and to uncover which corrective measures may be effective. The author concludes by recommending an integration of regulatory and patent reforms, with a call to action by scholars, scientists, representatives of the biopharmaceutical industry, and policy-makers.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
专利与个体化医疗的进展:以生物标志物研究为视角。
这篇文章讨论了个性化医疗的障碍,重点是新兴的生物标志物研究领域。作者首先将知识产权问题定义为不仅仅是行业激励的产物,并建议这些问题与个性化医疗面临的其他障碍(如监管框架缺陷)深深纠缠在一起。作者提出了一套未来的研究问题,以更充分地定义生物标志物研究的障碍,并揭示哪些纠正措施可能是有效的。作者最后建议将监管和专利改革结合起来,并呼吁学者、科学家、生物制药行业代表和决策者采取行动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Financial conflicts of interest in science. Beyond "safe and effective": the role of the federal government in supporting and disseminating comparative-effectiveness research. Putting together the pieces: recent proposals to fill in the genetic testing regulatory puzzle. Options for state and local governments to regulate non-cigarette tobacco products. Prescription data mining, medical privacy and the First Amendment: the U.S. Supreme Court in Sorrell v. IMS health Inc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1